Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
An announcement from Sihuan Pharmaceutical Holdings Group ( (HK:0460) ) is now available.
Sihuan Pharmaceutical has launched a share repurchase program under its existing mandate, buying back 8 million shares on the market at an average price of HK$1.2511 per share, equivalent to about 0.0874% of its issued share capital, with plans to hold these as treasury shares for future sale or transfer. The board frames the move as aligned with shareholder interests amid a pivotal turnaround year marked by a return to profit, stronger margins, and rapid expansion of its medical aesthetics franchise—now offering a full portfolio from botulinum toxin to aesthetic devices and expanding globally via a Swiss acquisition—alongside notable progress in its biopharmaceutical pipeline, including multiple drug approvals, NRDL inclusion, FDA Fast Track status, and the successful Hong Kong listing of subsidiary Xuanzhu Biopharm, which has boosted equity value, eased R&D funding pressure, and supports a shift into a new phase of higher-quality, growth-focused development.
The most recent analyst rating on (HK:0460) stock is a Hold with a HK$1.50 price target. To see the full list of analyst forecasts on Sihuan Pharmaceutical Holdings Group stock, see the HK:0460 Stock Forecast page.
More about Sihuan Pharmaceutical Holdings Group
Sihuan Pharmaceutical Holdings Group is an innovation-led international medical aesthetics and biopharmaceutical company founded in 2001 and listed in Hong Kong since 2010. It operates a comprehensive R&D platform, broad global product pipeline, efficient multi-dosage manufacturing capabilities, and a mature sales network, pursuing a dual-engine growth strategy in medical aesthetics and biopharmaceuticals to establish a leading position in China’s market.
YTD Price Performance: 93.89%
Average Trading Volume: 35,604,034
Technical Sentiment Signal: Buy
Current Market Cap: HK$11.85B
See more data about 0460 stock on TipRanks’ Stock Analysis page.